<p>U937 cells were treated either with STS (1 µM) or with TRAIL (50 ng/mL) in the presence or absence of zVD (5 µM) for 20 hrs. PJ-34 (1 µM) was added 1 hr before cell death was induced. (A) Column diagram of percentage of cells with high DiOC<sub>6</sub>(3) fluorescence intensity (n = 3). (B-C) PJ-34 (1 µM) considerably inhibited the (B) STS (n = 8) or (C) TRAIL-triggered (n = 8) secondary necrosis but not the necroptosis. Percentage of PI positive cells was determined. Values are mean±SD. *, P<0.05, **, P<0.01 and ***, P<0.001 calculated by Student’s t-probe. (D) Column diagram of percentage of cells with high AO fluorescence intensity (n = 2). (E) Dot plot distribution of cells stained with Annexin V-FITC and PI analyzed by flow cytometr...
<p>Apoptotic cell death after the addition of <i>Protochlamydia</i> (MOI 90) was estimated using the...
<p>(A) cells were pretreated with the indicated inhibitors, exposed to clofibrate (CF) and analysed ...
<p><b>(A)</b> No dose-dependent effect of Y-27632 on Caspase-3 activity under basal conditions. CSCs...
<p>U937 cells were treated either with STS (1 µM) or with TRAIL (50 ng/mL) in the presence or absenc...
<p>TRAIL-induced cell death in U937 cells. Cells were treated as indicated for 20 hrs. (A) Cytospins...
<p>(A-B) Nec (10 µM) and (C) GA (1 µM) significantly inhibited the STS-triggered necroptosis. Cells ...
<p>Both TRAIL and STS triggered necroptosis in caspase depleted U937 cells upon prolonged incubation...
<p>A) Phase contrast images (10x magnification) of NB7+Casp8 cells treated with vehicle, 1 µM APDC, ...
<p>(A) MiaPaCa-2 and BxPC-3 cells were cultured with TRAIL (50 ng/mL) for 12 h, and protein expressi...
<p>(<i>A</i>) shows that the cell death provoked by SecTRAPs is significantly decreased upon preincu...
<p>Cells (1×10<sup>5</sup>/ml) were grown for 18 hours and then left untreated or treated with TRAIL...
<p>(A-C) U2OS cells were transfected with control (black), Drp1 (green), or Mff (red) siRNA for 96 h...
<p>(A) Cell counts showing YFP (“loser” cells) cells first expand, then decline, in the presence of ...
<p>(A) Cytofluorimetric evaluation of apoptosis; representative Annexin V <i>versus</i> PI dot plot ...
<p>(A) Flow cytometric analysis of apoptosis after transfection with Flag-NS or the control vector. ...
<p>Apoptotic cell death after the addition of <i>Protochlamydia</i> (MOI 90) was estimated using the...
<p>(A) cells were pretreated with the indicated inhibitors, exposed to clofibrate (CF) and analysed ...
<p><b>(A)</b> No dose-dependent effect of Y-27632 on Caspase-3 activity under basal conditions. CSCs...
<p>U937 cells were treated either with STS (1 µM) or with TRAIL (50 ng/mL) in the presence or absenc...
<p>TRAIL-induced cell death in U937 cells. Cells were treated as indicated for 20 hrs. (A) Cytospins...
<p>(A-B) Nec (10 µM) and (C) GA (1 µM) significantly inhibited the STS-triggered necroptosis. Cells ...
<p>Both TRAIL and STS triggered necroptosis in caspase depleted U937 cells upon prolonged incubation...
<p>A) Phase contrast images (10x magnification) of NB7+Casp8 cells treated with vehicle, 1 µM APDC, ...
<p>(A) MiaPaCa-2 and BxPC-3 cells were cultured with TRAIL (50 ng/mL) for 12 h, and protein expressi...
<p>(<i>A</i>) shows that the cell death provoked by SecTRAPs is significantly decreased upon preincu...
<p>Cells (1×10<sup>5</sup>/ml) were grown for 18 hours and then left untreated or treated with TRAIL...
<p>(A-C) U2OS cells were transfected with control (black), Drp1 (green), or Mff (red) siRNA for 96 h...
<p>(A) Cell counts showing YFP (“loser” cells) cells first expand, then decline, in the presence of ...
<p>(A) Cytofluorimetric evaluation of apoptosis; representative Annexin V <i>versus</i> PI dot plot ...
<p>(A) Flow cytometric analysis of apoptosis after transfection with Flag-NS or the control vector. ...
<p>Apoptotic cell death after the addition of <i>Protochlamydia</i> (MOI 90) was estimated using the...
<p>(A) cells were pretreated with the indicated inhibitors, exposed to clofibrate (CF) and analysed ...
<p><b>(A)</b> No dose-dependent effect of Y-27632 on Caspase-3 activity under basal conditions. CSCs...